Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors

被引:119
作者
Brody, SA
Dulawa, SC
Conquet, F
Geyer, MA
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[3] Univ Lausanne, IBCM, GlaxoWellcome Expt Res, Lausanne, Switzerland
关键词
PPI; metabotropic glutamate; mGluR5; startle; prepulse inhibition; knockout mouse;
D O I
10.1038/sj.mp.4001404
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The glutamate hypothesis of schizophrenia derived from evidence that phencyclidine, a noncompetitive N-methyl-D-aspartate (NMDA) antagonist, produces schizophrenia-like symptoms in healthy humans. Sensorimotor gating, measured by prepulse inhibition (PPI), is a fundamental form of information processing that is deficient in schizophrenia patients and rodents treated with NMDA antagonists. Hence, PPI is widely used to study the neurobiology of schizophrenia. As the use of PPI as a model of gating deficits in schizophrenia has become more widespread, it has become increasingly important to assess such deficits accurately. Here we identify a possible role of mGluR5 in PPI by using wild type (WT) and mGluR5 knockout (KO) mice of two different background strains, 129SvPasIco and C57BL/6. In both strains, PPI was disrupted dramatically in the mGluR5 KO mice throughout a range of interstimulus intervals and sensory modalities. The present findings further support the glutamate hypothesis of schizophrenia and identify a functional role for mGluR5 in sensorimotor gating.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 38 条
  • [1] ABE T, 1992, J BIOL CHEM, V267, P13361
  • [2] ALLEN RM, 1978, AM J PSYCHIAT, V135, P1081
  • [3] [3H]methoxymethyl-3-[(2-methylyl-1,3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain:: In vitro and in vivo characterization
    Anderson, JJ
    Rao, SP
    Rowe, B
    Giracello, DR
    Holtz, G
    Chapman, DF
    Tehrani, L
    Bradbury, MJ
    Cosford, NDP
    Varney, MA
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (03) : 1044 - 1051
  • [4] Group I metabotropic glutamate receptors: Implications for brain diseases
    Bordi, F
    Ugolini, A
    [J]. PROGRESS IN NEUROBIOLOGY, 1999, 59 (01) : 55 - 79
  • [5] PRE-STIMULUS EFFECTS ON HUMAN STARTLE REFLEX IN NORMALS AND SCHIZOPHRENICS
    BRAFF, D
    STONE, C
    CALLAWAY, E
    GEYER, M
    GLICK, I
    BALI, L
    [J]. PSYCHOPHYSIOLOGY, 1978, 15 (04) : 339 - 343
  • [6] BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181
  • [7] BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206
  • [8] Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies
    Braff, DL
    Geyer, MA
    Swerdlow, NR
    [J]. PSYCHOPHARMACOLOGY, 2001, 156 (2-3) : 234 - 258
  • [9] Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice
    Chiamulera, C
    Epping-Jordan, MP
    Zocchi, A
    Marcon, C
    Cottiny, C
    Tacconi, S
    Corsi, M
    Orzi, F
    Conquet, F
    [J]. NATURE NEUROSCIENCE, 2001, 4 (09) : 873 - 874
  • [10] Conn PJ., 1994, METABOTROPIC GLUTAMA